Integrity Bio announces new manufacturing line

By The Science Advisory Board staff writers

June 9, 2020 -- Integrity Bio announced the validation of its second fill/finish manufacturing line in Thousand Oaks, CA. The plant expansion more than doubles the company's manufacturing capacity.

Integrity Bio provides formulation development, good manufacturing practices fill finish services, and drug delivery technologies to support the biotechnology and pharmaceutical industries.

The expanded manufacturing capacity will help the company meet growing demands and prioritize COVID-19 projects, according to Chief Executive Officer Michael Reilly. The new line will allow the company to fill over 20,000 liquid vials in a single batch.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.